May 1 |
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
Apr 29 |
Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
|
Apr 26 |
Cytokinetics names Sung Lee as CFO
|
Apr 24 |
Cytokinetics to Announce First Quarter Results on May 8, 2024
|
Apr 10 |
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
|
Apr 10 |
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
|
Apr 9 |
EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
|
Apr 5 |
Cytokinetics releases more data on hypertrophic cardiomyopathy drug aficamten
|
Apr 5 |
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
|
Apr 1 |
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|